课题基金 / 基金详情

项目摘要

项目成果

Charles E Schwartz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Intellectual disability (ID) is a common disability affecting 2-3% of the general population. X-linked ID (XLID) disorders, caused by defects of genes on the X chromosome, affect 1.7 of 1,000 males. Patients with ID require long-term family involvement, medical care and social services with enormous attendant burden and cost. XLID is a medically important and biologically significant group of disorders for which the prospects for further progress on the understanding of their molecular basis using traditional genetic approaches are low. The availability of finished sequence for the X chromosome and the enormous capability of the next generation sequencing methods offer an exciting new opportunity to identify the genetic bases of this highly heterogeneous group of disorders. The fact that males have a single X chromosome makes these disorders especially attractive targets for a large scale sequencing approach. Using next generation sequencing and gene expression analysis, this study intends to (1) obtain DNA sequence of all recognized, functionally important segments of the euchromatic portion of the X chromosome in probands from 35 known X-linked ID entities, (2) identify a minimum of 15 novel XLID genes, and (3) establish genotype/phenotype correlations for the novel XLID genes discovered in this project. Identification of genes that cause XLID is essential for clinical diagnosis, counseling, prevention, clinical management, and a rational development of effective novel treatments. Understanding the pathogenesis of ID will provide valuable insight into the mechanisms for normal development of human cognitive functions. We anticipate that the results of this study will lead to (1) new research projects to understand the function of these XLID genes in intellectual function; (2) novel molecular diagnostic methods; (3) innovative strategies for disease prevention and treatment; and (4) major and lasting economic and social impacts on the affected individuals, their families, and society.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Metabolic Biomarker for Autism Spectrum Disorder
  • 批准号:
    8285545
  • 项目类别:
  • 资助金额:
    $14.83万
  • 财政年份:
    2012
  • 负责人:
    Charles E Schwartz
  • 依托单位:
Novel Metabolic Biomarker for Autism Spectrum Disorder
  • 批准号:
    8440742
  • 项目类别:
  • 资助金额:
    $12.16万
  • 财政年份:
    2012
  • 负责人:
    Charles E Schwartz
  • 依托单位:
Identification of Novel X-linked Intellectual Disability Genes
  • 批准号:
    8471801
  • 项目类别:
  • 资助金额:
    $46.8万
  • 财政年份:
    2011
  • 负责人:
    Charles E Schwartz
  • 依托单位:
Identification of Novel X-linked Intellectual Disability Genes
  • 批准号:
    8084989
  • 项目类别:
  • 资助金额:
    $46.3万
  • 财政年份:
    2011
  • 负责人:
    Charles E Schwartz
  • 依托单位:
海外基金